Published in AIDS Weekly, August 25th, 2003
HIV PIs "acutely and reversibly inhibit the insulin-responsive glucose transporter Glut 4, leading to peripheral insulin resistance and impaired glucose tolerance," researchers in St. Louis explained. "Minimal modeling analysis of glucose tolerance tests on PI-treated patients has revealed an impaired insulin secretory response, suggesting additional pancreatic beta-cell dysfunction."
"To determine whether beta-cell function is acutely affected by PIs," J.C. Koster and colleagues at Washington University "assayed glucose-stimulated insulin secretion in rodent islets and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.